NCT06798363 2026-03-16
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
West China Hospital
Phase 2/3 Recruiting
Clinical Trials
9 trialsNCT05479123 2026-03-13
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
The University of Texas Health Science Center, Houston
Phase 4 Terminated
NCT07436611 2026-02-27
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
AFT Pharmaceuticals, Ltd.
Phase 2 Not yet recruiting
NCT07353385 2026-01-20
Enhanced Efficacy Through Optimization of Hemoporfin-Photodynamic Therapy Parameters in Port-Wine Stains
Second Affiliated Hospital of Xi'an Jiaotong University
Phase NA Completed
NCT07183644 2025-09-19
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
University of Texas Southwestern Medical Center
Phase NA Not yet recruiting
NCT07128459 2025-08-19
macrocheilia
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase NA Completed
NCT07104526 2025-08-05
Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)
Wuhan Integrated Traditional Chinese and Western Medicine Hospital
Phase NA Completed
NCT05477680 2025-05-16
BRASH
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05484219 2025-05-16
FUN
Sklifosovsky Institute of Emergency Care
Phase NA Suspended